0001000229-18-000059.txt : 20180403
0001000229-18-000059.hdr.sgml : 20180403
20180403172909
ACCESSION NUMBER: 0001000229-18-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180331
FILED AS OF DATE: 20180403
DATE AS OF CHANGE: 20180403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van Kempen Margaret Ann
CENTRAL INDEX KEY: 0001550876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14273
FILM NUMBER: 18734717
MAIL ADDRESS:
STREET 1: ATJEHWEG 16
CITY: NOORDWIJK
STATE: P7
ZIP: 2202 AP
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORE LABORATORIES N V
CENTRAL INDEX KEY: 0001000229
STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: STRAWINSKYLAAN 913
STREET 2: TOWER A, LEVEL 9
CITY: 1077 XX AMSTERDAM
STATE: P7
ZIP: 1077 XX
BUSINESS PHONE: 3124203191
MAIL ADDRESS:
STREET 1: 6316 WINDFERN
CITY: HOUSTON
STATE: TX
ZIP: 77040
4
1
wf-form4_152279093579691.xml
FORM 4
X0306
4
2018-03-31
0
0001000229
CORE LABORATORIES N V
CLB
0001550876
van Kempen Margaret Ann
ATJEHWEG 16
NOORDWIJK
P7
2202 AP
NETHERLANDS
1
0
0
0
Common Shares
2018-03-31
4
M
0
1436
0
A
3217
D
Common Shares
2018-03-31
4
F
0
747
0
D
2470
D
Common Shares
2018-04-01
4
M
0
1299
0
A
3769
D
Common Shares
2018-04-01
4
F
0
676
0
D
3093
D
Restricted Shares
0.0
2018-04-01
4
A
0
1387
0
A
Common Shares
1387.0
1387
D
Restricted Shares
0.0
2018-03-31
4
M
0
1436
0
D
Common Shares
1436.0
0
D
Restricted Shares
0.0
2018-04-01
4
M
0
1299
0
D
Common Shares
1299.0
0
D
The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2019, subject to the terms of issuance.
The Restricted Shares vested, without performance criteria, at the end of a three-year vesting period ending April 1, 2018, subject to the terms of issuance.
The Restricted Shares vested, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance.
/s/ Mark Elvig, Attorney-in-Fact
2018-03-31